Endogenously expressed estrogen receptors mediate neuroprotection in hippocampal cells (HT22)

Journal of Cellular Biochemistry

Volumn 95, Issue 2, 2005, Pages 302-312

  Deecher, Darlene C ^a   Daoud, Pamela ^a   Bhat, Ramesh A ^a   O'Connor, Lawrence T ^a,b  

^a PFIZER INC   (United States)

^b AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

Estrogen receptors; Estrogen responsive element; Genomic; Neuronal

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LUCIFERASE; NEUROTROPHIC FACTOR; RADIOLIGAND; RECEPTOR SUBTYPE; STEROID;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL LINE; CELL SPECIFICITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; LIGAND BINDING; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; DNA PRIMERS; ESTROGENS; GLUTAMIC ACID; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MICE; NEUROPROTECTIVE AGENTS; RADIOLIGAND ASSAY; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 26444517139     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20413     Document Type: Article

References (36)

1. Azcoitia I, Sierra A, Garcia-Segura LM. 1999. Neuroprotective effects of estradiol in the adult rat hippocampus: Interaction with insulin-like growth factor-I signalling. J Neurosci Res 58:815-822.
2. Beato M, Sánchez-Pacheco A. 1996. Interaction of steroid hormone receptors with the transcription initiation complex. Endocrine Rev 17:587-609.
3. Behl C, Widmann M, Trapp T, Holsboer F. 1995. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216: 473-482.
4. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. 1997. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol 51:535-541.
5. Bhavnani BR, Berco M, Binkley J. 2003. Equine estrogens differentially prevent neuronal cell death induced by glutamate. J Soc Gynecol Investig 10:302-308.
6. Bodine PV, Green J, Harris HA, Bhat RA, Stein GS, Lian JB, Komm BS. 1997. Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line. J Cell Biochem 65:368-387.
7. Deecher DC, Swiggard P, Frail DE, O'Connor LT. 2003. Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine 22:1-14.
8. Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM. 1999. Estradiol modulates bcl-2 in cerebral ischemia: A potential role for estrogen receptors. J Neurosci 19:6385-6393.
9. Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM. 2001. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA 98:1952-1957.
10. Fitzpatrick SL, Funkhouser JM, Sindoni DM, Stevis PE, Deecher DC, Bapat AR, Merchenthaler I, Frail DE. 1999. Expression of estrogen receptor-beta protein in rodent ovary. Endocrinology 140:2581-2591.
11. Fitzpatrick JL, Mize AL, Wade CB, Harris JA, Shapiro RA, Dorsa DM. 2002. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem 82:674-682.
12. Green PS, Gordon K, Simpkins JW. 1997. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63:229-235.
13. Green PS, Gridley KE, Simpkins JW. 1998. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84:7-10.
14. Gridley KE, Green PS, Simpkins JW. 1997. Low concentrations of estradiol reduce beta-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res 778: 158-165.
15. Gursoy E, Cardounel A, Al-khlaiwi T, Al-Drees A, Kalimi M. 2002. Tamoxifen protects clonal mouse hippocampal (HT-22) cells against neurotoxins-induced cell death. Neurochem Int 40:405-412.
16. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith JC. 2003. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 144: 4241-4249.
17. Linford NJ, Yang Y, Cook DG, Dorsa DM. 2001. Neuronal apoptosis resulting from high doses of the isoflavone genistein: Role for calcium and p42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther 299:67-75.
18. Mize AL, Shapiro RA, Dorsa DM. 2003. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144:306-312.
19. Moosmann B, Behl C. 1999. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci USA 96:8867-8872.
20. Norfleet AM, Thomas ML, Gametchu B, Watson CS. 1999. Estrogen receptor-alpha detected on the plasma membrane of aldehyde-fixed GH(3)/B6/F10 rat pituitary tumor cells by enzyme-linked immunocytochemistry. Endocrinology 140:3805-3814.
21. Shen ES, Meade EH, Perez MC, Deecher DC, Negrovilar A, Lopez FJ. 1998. Expression of functional estrogen receptors and galanin messenger ribonucleic acid in immortalized luteinizing hormone-releasing hormone neurons-Estrogenic control of galanin gene expression. Endocrinology 139:939-948.
22. Singer CA, Rogers KL, Dorsa DM. 1998. Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons. Neuroreport 9:2565-2568.
23. Singh M, Setalo G, Guan XP, Warren M, Toran-Allerand CD. 1999. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: Convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19:1179-1188.
24. Sohrabji F, Miranda RC, Toran-Allerand CD. 1995. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA 92:11110-11114.
25. Tang M, Abplanalp W, Ayres S, Subbiah MT. 1996. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metab Clin Exp 45:411-414.
26. Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I, Chambon P. 1989. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO J 8:1981-1986.
27. Toran-Allerand CD. 2004. Minireview: A plethora of estrogen receptors in the brain: where will it end? Endocrinology 145:1069-1074.
28. Toran-Allerand CD, Singh M, Setalo G. 1999. Novel mechanisms of estrogen action in the brain: New players in an old story [Review]. Front Neuroendocrinol 20:97-121.
29. Toran-Allerand CD, Guan X, MacLusky NJ, Horvath TL, Diano S, Singh M, Connolly ES, Jr., Nethrapalli IS, Tinnikov AA. 2002. ER-X: A novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 22:8391-8401.
30. Wade CB, Robinson S, Shapiro RA, Dorsa DM. 2001. Estrogen receptor (ER)alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology 142:2336-2342.
31. Wilson ME, Liu Y, Wise PM. 2002. Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res 102:48-54.
32. Wise PM. 2002. Estrogens and neuroprotection. Trends Endocrinol Metab 13:229-230.
33. Wise PM. 2003. Estrogens: Protective or risk factors in brain function? Prog Neurobiol 69:181-191.
34. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. 2002. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci USA 99: 14783-14788.
35. Yang RC, Shih HC, Hsu HK, Chang HC, Hsu C. 2003. Estradiol enhances the neurotoxicity of glutamate in GT(1-7) cells through an estrogen receptor-dependent mechanism. Neurotoxicology 24:65-73.
36. Zhang YQ, Shi J, Rajakumar G, Day AL, Simpkins JW. 1998. Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 784:321-324.